Skip to content

BillionToOne

US · BLLN #2109 by market cap Listed 2025
89.92 -0.28 -0.31%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

About BillionToOne

BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. Its patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. The was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.

Founded
2016
CEO
Dr. Oguzhan Atay, PhD
Employees
713
Headquarters
Menlo Park, California, United States of America
Fiscal year end
12-31
Website
billiontoone.com

Company profile

Exchange
US
Symbol
BLLN
Market-cap rank
#2109
Listing date
2025-11-06
Market cap
4.30B
Float cap
2.59B
Shares out
47.77M
Float shares
28.82M

Sectors & themes

Diagnostics & Research IPOs Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 20:01:12 · For reference only, not investment advice and not tailored to your situation.

BillionToOne discussion 0 comments

Add a comment